Pseudostat oral therapeutic vaccine: DLVRY began two Phase II trials

Cortecs International Ltd. (DLVRY), London, U.K. Product: Pseudostat oral therapeutic vaccine Indication: Chronic bronchitis in patients infected with Haemophilus influenzae and Pseudomonas aeruginosa...